Logo image of GRTX

GALERA THERAPEUTICS INC (GRTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:GRTX - US36338D1081 - Common Stock

0.145 USD
-0.07 (-32.59%)
Last: 6/3/2024, 8:18:13 PM
0.1379 USD
-0.01 (-4.9%)
After Hours: 6/3/2024, 8:18:13 PM
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to GRTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.38. This target is 163.79% above the current price.
GRTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GRTX.
In the previous month the buy percentage consensus was at a similar level.
GRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
GRTX Historical Analyst RatingsGRTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.150.250.380.380.53 - 74.14% 163.79% 163.79% 262.07%
GRTX Current Analyst RatingGRTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-08-29 Citigroup Maintains Neutral -> Neutral
2023-08-16 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-08-10 Piper Sandler Downgrade Overweight -> Neutral
2023-07-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-22 HC Wainwright & Co. Maintains Buy
2023-02-21 Piper Sandler Initiate Overweight
2023-02-16 B of A Securities Upgrade Underperform -> Buy
2023-02-16 HC Wainwright & Co. Reiterate Buy
2022-05-27 B of A Securities Downgrade Neutral -> Underperform
2021-12-20 Citigroup Maintains Buy
2021-12-15 BTIG Upgrade Neutral -> Buy
2021-12-15 HC Wainwright & Co. Upgrade Neutral -> Buy
2021-10-20 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-10-19 BTIG Downgrade Buy -> Neutral

GALERA THERAPEUTICS INC / GRTX FAQ

What is the average price target for GALERA THERAPEUTICS INC (GRTX) stock?

7 analysts have analysed GRTX and the average price target is 0.38 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 0.145.


What is the consensus rating for GALERA THERAPEUTICS INC (GRTX) stock?

The consensus rating for GALERA THERAPEUTICS INC (GRTX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


Can you provide the analyst count for GALERA THERAPEUTICS INC stock?

The number of analysts covering GALERA THERAPEUTICS INC (GRTX) is 7.